SCHEMBL3122279

SCHEMBL3122279

CCOC(=O)Cc1ccc(N(Cc2cccnc2)c2ccc(OC(F)F)c(OC(F)F)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
GRM2 Q14416 3/20 0.41
PDE4B Q07343 2/20 0.39
KMT2A Q03164 2/20 0.38
LMNA P02545 2/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
NR3C2 P08235 1/20 0.37
SYK P43405 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
DHODH Q02127 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3129693 0.94 GRM2 (0.44) ALDH1A1GRM2PDE4BKMT2ALMNA
SCHEMBL3199280 0.90 PDE4B (0.36) ALDH1A1PDE4BKMT2ALMNAMAPT
SCHEMBL3126203 0.88 NAPRT (0.46) ALDH1A1GRM2PDE4BKMT2ALMNA
SCHEMBL3215675 0.86 GAA (0.38) ALDH1A1KMT2ASYKGAADHFR
SCHEMBL3129231 0.85 PDE4B (0.38) GRM2PDE4BSYKPDE4APDE4C
SCHEMBL1157272 0.84 MAPT (0.45) ALDH1A1GRM2PDE4BKMT2ALMNA
SCHEMBL3210508 0.84 TRPM8 (0.37) PDE4BSYKTRPM8HTTPDE4A
SCHEMBL3118264 0.84 TP53 (0.44) ALDH1A1GRM2PDE4BKMT2ALMNA
SCHEMBL3131461 0.82 PDE4A (0.47) ALDH1A1GRM2PDE4BKMT2ALMNA
SCHEMBL3132226 0.82 PDE4B (0.43) PDE4BKMT2ALMNAPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
WO-2010003084-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B ALDH1A1 190/4885GRM2 3498/4885PDE4B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.